Anika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7
April 23 2020 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the
Company plans to issue its first quarter 2020 financial results
after the close of the market on Thursday, May 7, 2020 and hold its
investor conference call on the same day, Thursday, May 7, 2020, at
5:00 p.m. ET to discuss its financial results, business highlights,
and outlook.
The conference call can be accessed by dialing 1-855-468-0611
(toll-free domestic) or 1-484-756-4332 (international). A live
audio webcast will be available in the "Investor Relations" section
of Anika's website, www.anikatherapeutics.com. An accompanying
slide presentation also can be accessed via the Anika Therapeutics
website. The call will be archived and accessible on the same
website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated joint preservation and regenerative therapies company
based in Bedford, Mass. Anika is committed to delivering therapies
to improve the lives of patients across a continuum of care from
osteoarthritis pain management to joint preservation and
restoration. The company has more than two decades of global
expertise commercializing more than 20 products based on its
proprietary hyaluronic acid (HA) technology platform. For
more information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200423005145/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer
investorrelations@anikatherapeutics.com
For Media Inquiries: W2O Group Jeremy Berrington, 312-241-1995
jberrington@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024